Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guoping Wang

Showing results (451-460 of 469) with videos related to

Pageof 47
Sort By:
Iscience|September 28, 2023
Focalizing regions of biomarker relevance facilitates biomarker prediction on histopathological imagesJiefeng Gan, Hanchen Wang, Hui Yu, et al.
The Journal of Clinical Investigation|November 16, 2018
Lactate inhibits ATP6V0d2 expression in tumor-associated macrophages to promote HIF-2α-mediated tumor progressionNa Liu, Jing Luo, Dong Kuang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2008
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibitionSanjeev Shangary, Dongguang Qin, Donna McEachern, et al.
Nature Immunology|January 9, 2024
Breaking NGF-TrkA immunosuppression in melanoma sensitizes immunotherapy for durable memory T cell protectionTao Yin, Guoping Wang, Liuyang Wang, et al.
Journal of the American Society of Nephrology : JASN|August 23, 2020
Clinicopathological Features and Outcomes of Acute Kidney Injury in Critically Ill COVID-19 with Prolonged Disease Course: A Retrospective CohortPeng Xia, Yubing Wen, Yaqi Duan, et al.
European Journal of Neurology|May 10, 2024
A multicenter, randomized, open-label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravisJian Yin, Mingming Zhao, Xianhao Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2020
Transcriptional and proteomic insights into the host response in fatal COVID-19 casesMeng Wu, Yaobing Chen, Han Xia, et al.
European Urology|February 13, 2021
Androgen Receptor Splice Variant 7 Predicts Shorter Response in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Deprivation TherapyHeng Li, Yucong Zhang, Dong Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2020
Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to ImmunotherapyFeng Xie, Jianjun Zhang, Jiayin Wang, et al.
JAMA Neurology|December 29, 2025
Endovascular vs Medical Treatment of Basilar Artery Occlusion: 3-Year Outcomes of the ATTENTION Randomized Clinical TrialWei Hu, Chunrong Tao, Rui Li, et al.
Pageof 47

Showing results (451-460 of 469) with videos related to

Sort By:
Pageof 47
Iscience|September 28, 2023
Focalizing regions of biomarker relevance facilitates biomarker prediction on histopathological imagesJiefeng Gan, Hanchen Wang, Hui Yu, et al.
The Journal of Clinical Investigation|November 16, 2018
Lactate inhibits ATP6V0d2 expression in tumor-associated macrophages to promote HIF-2α-mediated tumor progressionNa Liu, Jing Luo, Dong Kuang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2008
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibitionSanjeev Shangary, Dongguang Qin, Donna McEachern, et al.
Nature Immunology|January 9, 2024
Breaking NGF-TrkA immunosuppression in melanoma sensitizes immunotherapy for durable memory T cell protectionTao Yin, Guoping Wang, Liuyang Wang, et al.
Journal of the American Society of Nephrology : JASN|August 23, 2020
Clinicopathological Features and Outcomes of Acute Kidney Injury in Critically Ill COVID-19 with Prolonged Disease Course: A Retrospective CohortPeng Xia, Yubing Wen, Yaqi Duan, et al.
European Journal of Neurology|May 10, 2024
A multicenter, randomized, open-label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravisJian Yin, Mingming Zhao, Xianhao Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2020
Transcriptional and proteomic insights into the host response in fatal COVID-19 casesMeng Wu, Yaobing Chen, Han Xia, et al.
European Urology|February 13, 2021
Androgen Receptor Splice Variant 7 Predicts Shorter Response in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Deprivation TherapyHeng Li, Yucong Zhang, Dong Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2020
Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to ImmunotherapyFeng Xie, Jianjun Zhang, Jiayin Wang, et al.
JAMA Neurology|December 29, 2025
Endovascular vs Medical Treatment of Basilar Artery Occlusion: 3-Year Outcomes of the ATTENTION Randomized Clinical TrialWei Hu, Chunrong Tao, Rui Li, et al.
Pageof 47